Glaxis Capital Management LLC acquired a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 10,000 shares of the company’s stock, valued at approximately $1,034,000. Novo Nordisk A/S accounts for approximately 3.6% of […]